Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items: 2018-2024

Historic Non-cash Items for OptimizeRx (OPRX) over the last 6 years, with FY2024 value amounting to $813397.0.

  • OptimizeRx's Non-cash Items fell 2223.74% to $813397.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $813397.0, marking a year-over-year decrease of 2223.74%. This contributed to the annual value of $813397.0 for FY2024, which is 2223.74% down from last year.
  • As of FY2024, OptimizeRx's Non-cash Items stood at $813397.0, which was down 2223.74% from $1.0 million recorded in FY2023.
  • In the past 5 years, OptimizeRx's Non-cash Items registered a high of $1.5 million during FY2020, and its lowest value of $156910.0 during FY2022.
  • For the 4-year period, OptimizeRx's Non-cash Items averaged around $890456.2, with its median value being $929698.5 (2023).
  • Per our database at Business Quant, OptimizeRx's Non-cash Items crashed by 9580.74% in 2020 and then soared by 56662.42% in 2023.
  • OptimizeRx's Non-cash Items (Annual) stood at $1.5 million in 2020, then tumbled by 89.85% to $156910.0 in 2022, then skyrocketed by 566.62% to $1.0 million in 2023, then dropped by 22.24% to $813397.0 in 2024.
  • Its Non-cash Items stands at $813397.0 for FY2024, versus $1.0 million for FY2023 and $156910.0 for FY2022.